TOday’s Movers: Mallinckrodt (NYSE:MNK) Stock Rating Maintained by Analysts at UBS; $70.0 Target Price Indicates 229.41 % Potential

December 7, 2017 - By Marry Poplack

 TOday’s Movers: Mallinckrodt (NYSE:MNK) Stock Rating Maintained by Analysts at UBS; $70.0 Target Price Indicates 229.41 % Potential

Investors sentiment decreased to 0.72 in 2017 Q2. Its down 0.30, from 1.02 in 2017Q1. It turned negative, as 49 investors sold Mallinckrodt Public Limited Company shares while 136 reduced holdings. 37 funds opened positions while 96 raised stakes. 95.02 million shares or 0.42% more from 94.62 million shares in 2017Q1 were reported.

Amalgamated Bank & Trust holds 0.03% or 19,626 shares. Susquehanna International Group Ltd Liability Partnership reported 0% in Mallinckrodt Public Limited Company (NYSE:MNK). Hall Laurie J Trustee stated it has 0% of its portfolio in Mallinckrodt Public Limited Company (NYSE:MNK). Bluemountain Capital Mngmt Lc accumulated 7,539 shares or 0.01% of the stock. Bancorporation Of America De stated it has 264,544 shares. United Capital Financial Advisers Ltd Llc holds 335,230 shares or 0.13% of its portfolio. Geode Cap Mgmt Ltd Com has 1.24 million shares. White Pine Capital Ltd has invested 0.21% in Mallinckrodt Public Limited Company (NYSE:MNK). The Pennsylvania-based Nationwide Fund Advsr has invested 0.01% in Mallinckrodt Public Limited Company (NYSE:MNK). West Oak Cap Limited Liability Company reported 92 shares. Alexandria Limited Liability Company holds 0% in Mallinckrodt Public Limited Company (NYSE:MNK) or 12 shares. Point72 Asia (Hong Kong) holds 0.01% or 149 shares in its portfolio. California State Teachers Retirement Sys, California-based fund reported 189,408 shares. Exxonmobil Mgmt Tx accumulated 19,074 shares. Glenmede Trust Na reported 476 shares stake.

Mallinckrodt (NYSE:MNK) Rating Reaffirmed

In a research note sent to investors on Friday, 6 October, The Buy rating of Mallinckrodt (NYSE:MNK) shares was kept by UBS, who now has a $70.0 TP on the stock. UBS’s TP means a possible upside of 229.41 % from the close price of the company.

Investors sentiment decreased to 0.72 in 2017 Q2. Its down 0.30, from 1.02 in 2017Q1. It turned negative, as 49 investors sold Mallinckrodt Public Limited Company shares while 136 reduced holdings. 37 funds opened positions while 96 raised stakes. 95.02 million shares or 0.42% more from 94.62 million shares in 2017Q1 were reported.

Amalgamated Bank & Trust holds 0.03% or 19,626 shares. Susquehanna International Group Ltd Liability Partnership reported 0% in Mallinckrodt Public Limited Company (NYSE:MNK). Hall Laurie J Trustee stated it has 0% of its portfolio in Mallinckrodt Public Limited Company (NYSE:MNK). Bluemountain Capital Mngmt Lc accumulated 7,539 shares or 0.01% of the stock. Bancorporation Of America De stated it has 264,544 shares. United Capital Financial Advisers Ltd Llc holds 335,230 shares or 0.13% of its portfolio. Geode Cap Mgmt Ltd Com has 1.24 million shares. White Pine Capital Ltd has invested 0.21% in Mallinckrodt Public Limited Company (NYSE:MNK). The Pennsylvania-based Nationwide Fund Advsr has invested 0.01% in Mallinckrodt Public Limited Company (NYSE:MNK). West Oak Cap Limited Liability Company reported 92 shares. Alexandria Limited Liability Company holds 0% in Mallinckrodt Public Limited Company (NYSE:MNK) or 12 shares. Point72 Asia (Hong Kong) holds 0.01% or 149 shares in its portfolio. California State Teachers Retirement Sys, California-based fund reported 189,408 shares. Exxonmobil Mgmt Tx accumulated 19,074 shares. Glenmede Trust Na reported 476 shares stake.

Mallinckrodt Public Limited Company (NYSE:MNK) Ratings Coverage

Among 21 analysts covering Mallinckrodt (NYSE:MNK), 9 have Buy rating, 0 Sell and 12 Hold. Therefore 43% are positive. Mallinckrodt has $218 highest and $24.0 lowest target. $69.42’s average target is 226.68% above currents $21.25 stock price. Mallinckrodt had 86 analyst reports since August 5, 2015 according to SRatingsIntel. Stifel Nicolaus initiated Mallinckrodt Public Limited Company (NYSE:MNK) on Friday, August 12 with “Buy” rating. The company was maintained on Wednesday, August 31 by Deutsche Bank. The rating was maintained by Piper Jaffray with “Buy” on Thursday, October 5. The stock of Mallinckrodt Public Limited Company (NYSE:MNK) has “Buy” rating given on Monday, August 7 by Mizuho. The firm has “Buy” rating by BMO Capital Markets given on Wednesday, August 16. Mizuho maintained Mallinckrodt Public Limited Company (NYSE:MNK) on Sunday, October 15 with “Hold” rating. Mizuho downgraded it to “Neutral” rating and $40 target in Wednesday, September 13 report. On Monday, April 24 the stock rating was maintained by Jefferies with “Buy”. The firm earned “Neutral” rating on Monday, June 6 by Goldman Sachs. The rating was maintained by Mizuho on Thursday, July 21 with “Buy”.

The stock decreased 0.47% or $0.1 during the last trading session, reaching $21.25. About 2.24 million shares traded. Mallinckrodt Public Limited Company (NYSE:MNK) has declined 30.39% since December 7, 2016 and is downtrending. It has underperformed by 47.09% the S&P500.

Mallinckrodt public limited company develops, makes, markets, and distributes branded and generic specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. The company has market cap of $2.02 billion. The companyÂ’s Specialty Brands segment markets branded pharmaceutical products for autoimmune and rare diseases, including the specialty areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and hemostasis products, and central nervous system drugs. It currently has negative earnings. This segment offers Acthar, an injectable drug for various indications, such as neurology, rheumatology, nephrology, and pulmonology; Ofirmev, an intravenous formulation of acetaminophen for pain management; Inomax for inhalation; Therakos, an immunotherapy treatment platform; and Exalgo, a form of hydromorphone.

More notable recent Mallinckrodt Public Limited Company (NYSE:MNK) news were published by: Seekingalpha.com which released: “Insiders Of Mallinckrodt Just Bought $1.4 Million Worth Of Stock” on December 05, 2017, also Seekingalpha.com with their article: “Mallinckrodt: Where Does It Go From Here?” published on November 09, 2017, Streetinsider.com published: “Mallinckrodt plc (MNK) PT Lowered to $40 at Piper Jaffray” on November 08, 2017. More interesting news about Mallinckrodt Public Limited Company (NYSE:MNK) were released by: Streetinsider.com and their article: “Wells Fargo Downgrades Mallinckrodt plc (MNK) to Market Perform” published on November 08, 2017 as well as Seekingalpha.com‘s news article titled: “Express Scripts Sells Unit With Ties To Mallinckrodt’s Acthar” with publication date: November 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.